In pathological states such as atherosclerosis, myocardial infarction, ischemia–reperfusion injury (IRI), pulmonary hypertension, and heart failure, CD47 is frequently upregulated, thereby impairing efferocytosis, sustaining inflammation, and limiting reparative angiogenesis. The gene discussed is CD47; the disease is pulmonary arterial hypertension.